kidney · Mechanism Report
Does elevated cystatin C with normal UACR indicate reduced kidney filtration?
Elevated cystatin C with reduced cystatin C-based eGFR generally indicates reduced kidney filtration, and a normal UACR points to a non-albuminuric CKD phenotype rather than excluding CKD.
This is what AI claimed
Elevated cystatin C with a reduced cystatin C–based eGFR indicates reduced kidney filtration, while a normal urine albumin-to-creatinine ratio identifies a non-albuminuric phenotype rather than excluding chronic kidney disease.
Executive summary
The claim says these findings are not contradictory: reduced cystatin C-based eGFR reflects lower filtration, while normal urine albumin supports an A1 or non-albuminuric pattern. The graph frames cystatin C as a filtration marker that can be influenced by non-GFR factors such as glucocorticoids or hyperthyroidism, so the result should be interpreted in clinical context and, when needed, confirmed over time.
Verified conclusion
Reduced cystatin C–based eGFR and normal albumin excretion are not contradictory. Together, they can describe reduced filtration with an A1/non-albuminuric phenotype, provided the abnormality is persistent and interpreted in clinical context.
Filtration and CKD classification
- Elevated cystatin C with reduced eGFRcys is a well-supported indicator of lower GFR. The CKD-EPI 2012 cystatin C equation had 84.6% of estimates within 30% of measured GFR in validation; in a Swedish iohexol-GFR cohort, 82.5% were within 30% and 58.3% within 10%.
- A UACR <30 mg/g is KDIGO A1 (“normal to mildly increased”) albuminuria. It describes albumin excretion, not whether CKD is present.
- Persistent eGFR <60 mL/min/1.73 m² for >3 months establishes CKD regardless of UACR. With UACR <30 mg/g, this is appropriately termed non-albuminuric CKD.
Mechanistic and interpretive considerations
- Cystatin C is not exclusively determined by filtration. Systemic glucocorticoids and hyperthyroidism can increase cystatin C, making eGFRcys falsely low; hypothyroidism can have the opposite effect. Severe inflammation and catabolic states can also complicate interpretation.
- Therefore, discordance between eGFRcys, creatinine-based eGFR, and the clinical picture warrants review of medications, thyroid status, and systemic illness. Combined creatinine–cystatin C eGFR improves diagnostic/staging accuracy; measured GFR is appropriate when precision would alter a high-stakes decision.
Clinical implications
- A normal UACR does not imply negligible risk: risk rises as eGFR declines even without albuminuria, while albuminuria adds further risk at a given eGFR. Cardiovascular risk may rise at UACR values above approximately 10 mg/g, even below the 30-mg/g threshold.
Bottom line
- The claim is supported: reduced eGFRcys generally indicates reduced filtration, and normal UACR identifies an A1/non-albuminuric phenotype rather than excluding CKD. Confirmation with repeat testing over >3 months is essential.
References
- KDIGO-2024-CKD-Guideline.pdf — kdigo.org
- Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness — pmc.ncbi.nlm.nih.gov
- KDIGO 2024 clinical practice guideline on evaluation and ... - PMC — pmc.ncbi.nlm.nih.gov
- Demographics & eGFR Accuracy - NIDDK — niddk.nih.gov
- #4506 ACCURACY OF NOVEL GFR ESTIMATING ... — academic.oup.com
- CVD risk in non-albuminuric chronic kidney disease in ... — ncbi.nlm.nih.gov
- Which is the best glomerular filtration marker: Creatinine, cystatin C ... — onlinelibrary.wiley.com
See a full patient report verified like this
Book a walkthrough